Holocene Advisors, LP Abb Vie Inc. Call Options Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $109 Million - $123 Million	791,500 New	791,500 $123 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $292 Million - $363 Million	-2,216,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $28.3 Million - $35.8 Million	263,200 Added 13.48%	2,216,200 $300 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $110 Million - $125 Million	1,034,300 Added 112.58%	1,953,000 $211 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.97 Million - $2.19 Million	18,700 Added 2.08%	918,700 $103 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $92.1 Million - $101 Million	900,000 New	900,000 $97.4 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.